Psoriasis Clinical Trials in New York

Showing 161-180 of 198 trials

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

NCT00504270

This study will investigate the safety, efficacy and pharmacokinetics of R3421 in patients with moderate to severe chronic plaque psoriasis. Patients will be randomized to one of 3 treatment groups to receive once daily oral treatment with a)R3421 20mg, b)R3421 120mg, or c)placebo. The anticipated time on study treatment is \<3 months, and the target sample size is \<100 individuals.

Psoriasis

Hoffmann-La Roche66 participantsStarted Jul 2007

Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States • Santa Monica, California, United States +12 more locations

TERMINATEDPhase 2< 1 mile

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

NCT02201524

Study B7451005 is a Phase 2 study which will assess the efficacy and safety of PF-04965842 in patients with moderate to severe psoriasis. The study will include three PF-04965842 groups (200 mg daily, 400 mg daily and 200 mg twice daily) and a placebo group. The treatment period will be 4 weeks in duration and will be followed up by a 4 week follow up period.

Plaque Psoriasis

Pfizer59 participantsStarted Nov 2014

Birmingham, Alabama, United States • Rogers, Arkansas, United States • Encinitas, California, United States +42 more locations

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Psoriasis Trials in Other Cities

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

An Exploratory Genetic Study in Participants With Psoriasis

Cell Responses to IFN-gamma

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Evaluate the Effect of Elimune Capsules

T and B Cell Responses in Autoimmune Diseases

Tofacitinib Ointment For Chronic Plaque Psoriasis

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

Other Conditions in New York